A new blood test based on 10 "biomarker" proteins will make it possible to test new treatments at an early stage of Alzheimer's progression.
Writing in the journal Alzheimer's & Dementia, researchers from King's College London describe how they investigated 26 proteins previously associated with Alzheimer's disease.
They analysed blood samples from 476 confirmed Alzheimer's patients, 220 individuals with "mild cognitive impairment" (MCI) who experienced occasional memory loss, and 450 healthy elderly people.
In the vast majority of cases, memory lapses do not lead to Alzheimer's. But the researchers identified 10 blood proteins that appeared in 87% of MCI patients diagnosed with the disease within a year.
More top news
Police believe it is a "distinct possibility" that Halliwell was a serial killer, beyond the two murders he was convicted for.
The bodies were seen lined up in white and black body bags along Libya's western shoreline in stark and grim images released by aid workers.
Rebecca Steinfeld, 35, and Charles Keidan, 40, objected to the "patriarchal baggage" of "the institution of marriage".